Mounjaro®
Starting from £179.99/mo
Start journey Learn moreBlood in stool while taking Mounjaro is not listed as a common or expected side effect of tirzepatide, but it is a symptom that always warrants attention. If you notice bright red blood, dark tarry stools, or any rectal bleeding during treatment, the right move is to contact a doctor or call 111 the same day — do not wait for your next scheduled review. Mounjaro works by slowing gastric emptying and reducing appetite through dual GIP and GLP-1 receptor activity, which can cause significant changes to your digestive system. Most of those changes produce nausea, looser stools or constipation rather than bleeding. So when blood appears, the question worth asking is not simply "is this the medicine?" but "what does this symptom need from me right now?"
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
That is the central decision, and it is genuinely important not to assume the answer either way. Many people starting Mounjaro notice real, sometimes dramatic changes to their digestion, looser stools, more frequent trips to the bathroom, urgency, or the reverse: constipation and bloating. The NHS medicines page for tirzepatide lists these gastrointestinal effects as common, meaning they affect at least 1 in 10 users.
Blood is not on that list. It is not described as a common or expected effect of tirzepatide in the licensed prescribing information. So the first question is not "could Mounjaro cause this?" but "does this symptom need medical assessment today?"
The practical answer depends on what the blood looks like. Bright red blood on the paper or in the bowl after straining is often haemorrhoidal, piles that were already present can become more irritated when stool consistency changes, which Mounjaro regularly does. That still needs a GP review, but it is a different level of urgency than passing dark, sticky, tar-like stools, which can indicate bleeding higher in the gut and should prompt a same-day call to 111 or a visit to urgent care. When in doubt, treat it as urgent.
Tirzepatide slows the rate at which food moves from the stomach into the small intestine. This is part of why it reduces appetite so effectively, but it also means the gut is doing something measurably different to what it did before. Stool changes on Mounjaro are real and well-documented; you can read more about how the medicine affects stool consistency in our guide to loose stool on Mounjaro.
One misconception worth setting down gently: some people assume any new symptom during treatment must be caused by the medicine. That is understandable, you start something new, something changes, and the mind connects the dots. But the timing of a symptom does not confirm the cause. Bleeding in the gastrointestinal tract has a long list of possible origins, most of which have nothing to do with tirzepatide: haemorrhoids aggravated by dietary change, an anal fissure from harder stools, an undiagnosed bowel condition, or something that simply coincides with starting treatment.
Straining, dehydration (particularly relevant if nausea has reduced your fluid intake), and changes in fibre consumption can all contribute to minor rectal trauma. None of these are emergencies, but all of them are worth discussing with your prescriber or GP.
The MHRA asks patients to report unexpected or serious symptoms experienced on any medicine via the Yellow Card scheme, this helps build the post-market safety picture for newer medicines like tirzepatide. Reporting takes around ten minutes online and does not require a formal diagnosis first.
When you contact a clinician, it helps to describe the symptom precisely: how much blood, what colour, how long it has been happening, whether there is any associated pain, and any other recent changes to your stool. If you have also noticed mucus in your stool alongside the blood, mention that too, the combination can point a doctor toward a specific cause more quickly.
For most people on Mounjaro whose only finding is a small amount of bright red blood after a period of changed stool habits, the outcome of a GP review is reassurance and a few practical adjustments to hydration and diet. For a smaller number, it prompts investigation of something that would have needed attention regardless of their weight-loss treatment. Either outcome is worth having sooner rather than later.
If you have questions about your treatment or want to understand more about how Mounjaro is monitored and reviewed at each stage, our Mounjaro treatment guide covers the clinical framework in full. Separately, the broader picture of tirzepatide as a medicine (its mechanism, its trial history, and its UK licensing) is worth reading if you want the science behind what your gut is responding to.
Mounjaro does not routinely require blood tests simply to monitor for gastrointestinal bleeding. But your prescriber may want to check inflammatory markers, haemoglobin or iron levels if blood in stool is a recurring feature, particularly if you also feel more tired than usual. Our page on blood tests and Mounjaro explains which monitoring is typically relevant at different stages of treatment.
One practical point: if you are considering a private route to treatment and are comparing costs, it is reasonable to factor in what clinical support is actually included at each price point. A Mounjaro price comparison is useful, but the more relevant question is whether the service reviewing your prescription has a mechanism to respond quickly when you report something unexpected. Symptoms like blood in stool are exactly where aftercare matters.
If you are ready to discuss Mounjaro with a clinician, or you have an existing concern about your current treatment, our prescribers review consultations the same day they are submitted. Speak to our prescribers for a clinical assessment of whether Mounjaro is appropriate for you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.